Gastrointestinal Symptoms are Still Prevalent and Negatively Impact Health-Related Quality of Life: A Large Cross-Sectional Population Based Study in The Netherlands

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Tielemans, Merel M ^a,b   Jaspers Focks, Jeroen ^a   van Rossum, Leo G M ^a   Eikendal, Ties ^a   Jansen, Jan B M J ^a,c   Laheij, Robert J F ^b   van Oijen, Martijn G H ^b,d  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c ELKERLIEK HOSPITAL   (Netherlands)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTACID AGENT; ANTIDEPRESSANT AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PROTON PUMP INHIBITOR;

ADULT; AGED; ANOREXIA; ARTICLE; ASTHMA; BLOATING; BORBORYGMI; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONSTIPATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEFECATION DISORDER; DIARRHEA; DRUG USE; DYSPHAGIA; EPIGASTRIC PAIN; FEMALE; FLATULENCE; GASTROESOPHAGEAL REFLUX; GASTROINSTESTINAL EMPTY FEELING; GASTROINTESTINAL BELCHING; GASTROINTESTINAL SYMPTOM; HEARTBURN; HEMATEMESIS; HUMAN; LOWER ABDOMINAL PAIN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NETHERLANDS; POPULATION RESEARCH; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; SATIETY; SEX RATIO; VOMITING;

ADOLESCENT; ADULT; AGED; CHILD; CROSS-SECTIONAL STUDIES; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 84880830269     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069876     Document Type: Article

References (53)

1. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ, 3rd (1992) Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 102: 1259-1268.
2. Nyrop KA, Palsson OS, Levy RL, Korff MV, Feld AD, et al. (2007) Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain. Aliment Pharmacol Ther 26: 237-248.
3. Jones RH, Lydeard SE, Hobbs FD, Kenkre JE, Williams EI, et al. (1990) Dyspepsia in England and Scotland. Gut 31: 401-405.
4. Kay L, Jorgensen T, (1994) Epidemiology of upper dyspepsia in a random population. Prevalence, incidence, natural history, and risk factors. Scand J Gastroenterol 29: 2-6.
5. Agreus L, Svardsudd K, Nyren O, Tibblin G, (1995) Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 109: 671-680.
6. Bernersen B, Johnsen R, Straume B, (1996) Non-ulcer dyspepsia and peptic ulcer: the distribution in a population and their relation to risk factors. Gut 38: 822-825.
7. Jones R, Lydeard S, (1989) Prevalence of symptoms of dyspepsia in the community. BMJ 298: 30-32.
8. Penston JG, Pounder RE, (1996) A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 10: 83-89.
9. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ, 3rd (1994) Smoking, alcohol, and analgesics in dyspepsia and among dyspepsia subgroups: lack of an association in a community. Gut 35: 619-624.
10. Holtmann G, Goebell H, Talley NJ, (1994) Dyspepsia in consulters and non-consulters: prevalence, health-care seeking behaviour and risk factors. European Journal of Gastroenterology & Hepatology 6: 917-924.
11. Shaib Y, El-Serag HB, (2004) The prevalence and risk factors of functional dyspepsia in a multiethnic population in the United States. Am J Gastroenterol 99: 2210-2216.
12. El-Serag HB, Talley NJ, (2004) Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther 19: 643-654.
13. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, et al. (2007) Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 56: 772-781.
14. Miendje Deyi VY, Vanderpas J, Bontems P, Van den Borre C, De Koster E, et al. (2011) Marching cohort of Helicobacter pylori infection over two decades (1988-2007): combined effects of secular trend and population migration. Epidemiol Infect 139: 572-580.
15. van Marrewijk CJ, Mujakovic S, Fransen GA, Numans ME, de Wit NJ, et al. (2009) Effect and cost-effectiveness of step-up versus step-down treatment with antacids, H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial. Lancet 373: 215-225.
16. Fox M, Forgacs I, (2006) Gastro-oesophageal reflux disease. BMJ 332: 88-93.
17. Rotman SR, Bishop TF (2013) Proton Pump Inhibitor Use in the U.S. Ambulatory Setting, 2002-2009. PLos ONE 8.
18. Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, et al. (2008) ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol 52: 1502-1517.
19. Delgado-Aros S, Locke GR, 3rd, Camilleri M, Talley NJ, Fett S, et al (2004) Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol 99: 1801-1806.
20. Cremonini F, Locke GR, 3rd, Schleck CD, Zinsmeister AR, Talley NJ (2006) Relationship between upper gastrointestinal symptoms and changes in body weight in a population-based cohort. Neurogastroenterol Motil 18: 987-994.
21. Haag S, Andrews JM, Gapasin J, Gerken G, Keller A, et al. (2011) A 13-nation population survey of upper gastrointestinal symptoms: prevalence of symptoms and socioeconomic factors. Aliment Pharmacol Ther 33: 722-729.
22. Halder SL, Locke GR, 3rd, Talley NJ, Fett SL, Zinsmeister AR, et al (2004) Impact of functional gastrointestinal disorders on health-related quality of life: a population-based case-control study. Aliment Pharmacol Ther 19: 233-242.
23. Kaji M, Fujiwara Y, Shiba M, Kohata Y, Yamagami H, et al. (2010) Prevalence of overlaps between GERD, FD and IBS and impact on health-related quality of life. J Gastroenterol Hepatol 25: 1151-1156.
24. Koloski NA, Talley NJ, Boyce PM, (2000) The impact of functional gastrointestinal disorders on quality of life. Am J Gastroenterol 95: 67-71.
25. van Kerkhoven LA, Eikendal T, Laheij RJ, van Oijen MG, Jansen JB, (2008) Gastrointestinal symptoms are still common in a general Western population. Neth J Med 66: 18-22.
26. Bovenschen HJ, Janssen MJ, van Oijen MG, Laheij RJ, van Rossum LG, et al. (2006) Evaluation of a gastrointestinal symptoms questionnaire. Dig Dis Sci 51: 1509-1515.
27. Likert R (1932) A technique for the measurement of attitudes. Archives of Psychology 140.
28. Brooks R, (1996) EuroQol: the current state of play. Health Policy 37: 53-72.
29. Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ, (2005) [Measuring the quality of life in economic evaluations: the Dutch EQ-5D tariff]. Ned Tijdschr Geneeskd 149: 1574-1578.
30. (NHG) DCoGP (2011) Multidisciplinary guideline cardiovascular risk management.
31. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894: i-xii, 1-253, (2000).
32. van Dam RM, (2006) [Coffee consumption and the decreased risk of diabetes mellitus type 2]. Ned Tijdschr Geneeskd 150: 1821-1825.
33. Piessevaux H, De Winter B, Louis E, Muls V, De Looze D, et al. (2009) Dyspeptic symptoms in the general population: a factor and cluster analysis of symptom groupings. Neurogastroenterol Motil 21: 378-388.
34. Havemann BD, Henderson CA, El-Serag HB, (2007) The association between gastro-oesophageal reflux disease and asthma: a systematic review. Gut 56: 1654-1664.
35. Powell N, Huntley B, Beech T, Knight W, (2008) Upper gastrointestinal symptoms and asthma: a manifestation of allergy? Gut 57: 1026-1027.
36. Gadel AA, Mostafa M, Younis A, Haleem M, (2012) Esophageal motility pattern and gastro-esophageal reflux in chronic obstructive pulmonary disease. Hepatogastroenterology 59: 2498-2502.
37. Kamble NL, Khan NA, Kumar N, Nayak HK, Daga MK (2012) A study of gastro-oesophageal reflux disease (GORD) in patients with mild to moderate COPD in India. Respirology.
38. Liang BM, Feng YL, (2012) Association of gastroesophageal reflux disease symptoms with stable chronic obstructive pulmonary disease. Lung 190: 277-282.
39. Van Oudenhove L, Vandenberghe J, Demyttenaere K, Tack J, (2010) Psychosocial factors, psychiatric illness and functional gastrointestinal disorders: a historical perspective. Digestion 82: 201-210.
40. Levy RL, Olden KW, Naliboff BD, Bradley LA, Francisconi C, et al. (2006) Psychosocial aspects of the functional gastrointestinal disorders. Gastroenterology 130: 1447-1458.
41. Gonella G, Baignoli G, Ecari U, (1990) Fluvoxamine and imipramine in the treatment of depressive patients: a double-blind controlled study. Curr Med Res Opin 12: 177-184.
42. Norton KR, Sireling LI, Bhat AV, Rao B, Paykel ES, (1984) A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients. J Affect Disord 7: 297-308.
43. Trindade E, Menon D, Topfer LA, Coloma C, (1998) Adverse effects associated with selective serotonin reuptake inhibitors and tricyclic antidepressants: a meta-analysis. CMAJ 159: 1245-1252.
44. Hojo M, Miwa H, Yokoyama T, Ohkusa T, Nagahara A, et al. (2005) Treatment of functional dyspepsia with antianxiety or antidepressive agents: systematic review. J Gastroenterol 40: 1036-1042.
45. Ford AC, Talley NJ, Schoenfeld PS, Quigley EM, Moayyedi P, (2009) Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 58: 367-378.
46. Rahimi R, Nikfar S, Rezaie A, Abdollahi M, (2009) Efficacy of tricyclic antidepressants in irritable bowel syndrome: a meta-analysis. World J Gastroenterol 15: 1548-1553.
47. Mak AD, Wu JC, Chan Y, Chan FK, Sung JJ, et al. (2012) Dyspepsia is strongly associated with major depression and generalised anxiety disorder- a community study. Aliment Pharmacol Ther 36: 800-810.
48. Dong YY, Chen FX, Yu YB, Du C, Qi QQ, et al. (2013) A school-based study with Rome III criteria on the prevalence of functional gastrointestinal disorders in Chinese college and university students. PLoS One 8: e54183.
49. Halder SL, Locke GR, 3rd, Schleck CD, Zinsmeister AR, Melton LJ, 3rd, et al (2007) Natural history of functional gastrointestinal disorders: a 12-year longitudinal population-based study. Gastroenterology 133: 799-807.
50. Groeneveld PW, Lieu TA, Fendrick AM, Hurley LB, Ackerson LM, et al. (2001) Quality of life measurement clarifies the cost-effectiveness of Helicobacter pylori eradication in peptic ulcer disease and uninvestigated dyspepsia. Am J Gastroenterol 96: 338-347.
51. Galea S, Tracy M, (2007) Participation rates in epidemiologic studies. Ann Epidemiol 17: 643-653.
52. Morton LM, Cahill J, Hartge P, (2006) Reporting participation in epidemiologic studies: a survey of practice. Am J Epidemiol 163: 197-203.
53. Baan CA, Poos MJJC (2011) Hoe vaak komt diabetes mellitus voor en hoeveel mensen sterven eraan? In: Ministry of Health WaS, editor. National Public Health Compass: National Institute of Public Health and the Environment (RIVM).